.png){kind=logo}
GC Asia
Copying and distributing are prohibited without permission of the publisher.
Glaxo drinks deep with $9bn bond as US brims with cash
It was another $30bn week in the all-guns-blazing US investment grade bond market, but the clear star of the show was the $9bn four tranche offering for UK pharmaceutical firm GlaxoSmithKline, which pulled a staggering $17.8bn of orders.
Already a subscriber? Login
08 May 2008
-
Latest news from Corporate Bonds
-
London housing associations plot ESG bond splurge
26 Jul 2021 -
Nasdaq heads to euros after spinoff announcement
26 Jul 2021 -
Luso Bank prints Macau’s inaugural Panda bond
26 Jul 2021 -
Market woes take toll on bonds
26 Jul 2021 -
GC Podcast: Revised guidance — ECB hunkers down for the long haul
23 Jul 2021
-
-
Latest news from Corporate Bonds
-
London housing associations plot ESG bond splurge
26 Jul 2021 -
Nasdaq heads to euros after spinoff announcement
26 Jul 2021 -
Luso Bank prints Macau’s inaugural Panda bond
26 Jul 2021 -
Market woes take toll on bonds
26 Jul 2021 -
GC Podcast: Revised guidance — ECB hunkers down for the long haul
23 Jul 2021
-
